首页/数据集/Agreement between EORTC criteria and PERCIST (reader 2).

Agreement between EORTC criteria and PERCIST (reader 2).

Figshare2018-07-16 更新2026-04-29 收录

肿瘤疗效评估

医学影像诊断一致性

数据链接：

https://figshare.com/articles/dataset/Agreement_between_EORTC_criteria_and_PERCIST_reader_2_/6821474 数据链接链接失效反馈

官方服务：

资源简介：

Agreement between EORTC criteria and PERCIST (reader 2).

应用场景：

创建时间：

2018-07-16

相关数据集

xpertsystems/hconc012-sample

化疗毒性预测

肿瘤疗效评估

HC-ONC-012数据集是一个完全合成的多癌种化疗反应队列样本，包含500名患者的单表数据，涵盖18种癌症类型（如NSCLC、乳腺癌、结直肠癌等）和60多种化疗方案（如FOLFOX、FOLFIRINOX、R-CHOP等）。数据集采用CTCAE v5.0毒性分级标准（15个毒性类别）、RECIST 1.1和iRECIST反应评估，并包括癌症特异性生物标志物面板（如EGFR、HER2、MSI等）、剂

Hugging Face2026-05-27 更新140

Criteria for response evaluation and standard definitions.

肿瘤疗效评估

医学标准定义

WHO, World Health Organization; RECIST, Response Evaluation Criteria in Solid Tumors; JRSGC, Japanese Research Society for Gastric Carcinoma; CR, complete response; PR, partial response; PD, progressi

NIAID Data Ecosystem80

Cohen’s Kappa statistic to test inter-rater reliability between the radiologists.

医学影像诊断一致性

评分者间信度检验

Cohen’s Kappa statistic to test inter-rater reliability between the radiologists.

Figshare2021-08-10 更新30

SUV results before and after treatment for all identified ROIs.

肿瘤疗效评估

医学影像量化

SUV results before and after treatment for all identified ROIs.

NIAID Data Ecosystem90

Tumor Response, TTP and OS in the 10 noncomparative studies.

肿瘤疗效评估

临床终点分析

Abbreviations: DCR, disease control rate; NA: not available; OS, overall survival; RECIST, response evaluation in solid tumors; TTP, time to progression.

NIAID Data Ecosystem60